Search by Drug Name or NDC
NDC 59651-0009-60 Ranolazine 500 mg/1 Details
Ranolazine 500 mg/1
Ranolazine is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is RANOLAZINE.
Product Information
NDC | 59651-0009 |
---|---|
Product ID | 59651-009_49873158-5c0a-41da-86a2-369ef6b0cbc8 |
Associated GPIs | |
GCN Sequence Number | 060333 |
GCN Sequence Number Description | ranolazine TAB ER 12H 500 MG ORAL |
HIC3 | A2C |
HIC3 Description | ANTIANGINAL, ANTI-ISCHEMIC AGENTS,NON-HEMODYNAMIC |
GCN | 26459 |
HICL Sequence Number | 033446 |
HICL Sequence Number Description | RANOLAZINE |
Brand/Generic | Generic |
Proprietary Name | Ranolazine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Ranolazine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
Route | ORAL |
Active Ingredient Strength | 500 |
Active Ingredient Units | mg/1 |
Substance Name | RANOLAZINE |
Labeler Name | Aurobindo Pharma Limited |
Pharmaceutical Class | Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA209081 |
Listing Certified Through | 2024-12-31 |
Package
NDC 59651-0009-60 (59651000960)
NDC Package Code | 59651-009-60 |
---|---|
Billing NDC | 59651000960 |
Package | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-009-60) |
Marketing Start Date | 2022-12-23 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.25719 |
Pricing Unit | EA |
Effective Date | 2024-02-21 |
NDC Description | RANOLAZINE ER 500 MG TABLET |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 1 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis